147 related articles for article (PubMed ID: 23210914)
21. [Characteristics and outcomes of primary angiosarcoma].
Zhang ZY; Cheng YJ; Gong XL; Ge YP; Bai CM; Wang XJ; Miao Q; Zhang FQ
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):693-697. PubMed ID: 31550860
[No Abstract] [Full Text] [Related]
22. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
Mody MD; Gill HS; Saba NF
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel.
Kajihara I; Kanemaru H; Miyake T; Aoi J; Masuguchi S; Fukushima S; Jinnin M; Ihn H
Drug Discov Ther; 2015 Feb; 9(1):75-7. PubMed ID: 25788055
[TBL] [Abstract][Full Text] [Related]
24. Is there a taxane-free interval that predicts response to taxanes as a later-line treatment of recurrent ovarian or primary peritoneal cancer?
McCourt C; Dessie S; Bradley AM; Schwartz J; Brard L; Dizon DS
Int J Gynecol Cancer; 2009 Apr; 19(3):343-7. PubMed ID: 19407557
[TBL] [Abstract][Full Text] [Related]
25. Primary breast angiosarcoma - a single institution experience from a tertiary cancer center in South India.
Lokanatha D; Anand A; Lakshmaiah KC; Govind Babu K; Jacob LA; Suresh Babu MC; Lokesh KN; Rudresha AH; Rajeev LK; Saldanha SC; Giri GV; Koppaka D; Kumar RV
Breast Dis; 2018; 37(3):133-138. PubMed ID: 29286911
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel.
Isogai R; Kawada A; Aragane Y; Tezuka T
J Dermatol; 2004 Apr; 31(4):335-41. PubMed ID: 15187330
[TBL] [Abstract][Full Text] [Related]
27. Angiosarcoma of the breast: a difficult surgical challenge.
Hui A; Henderson M; Speakman D; Skandarajah A
Breast; 2012 Aug; 21(4):584-9. PubMed ID: 22305554
[TBL] [Abstract][Full Text] [Related]
28. Modern outcomes of inflammatory breast cancer.
Rehman S; Reddy CA; Tendulkar RD
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):619-24. PubMed ID: 22445003
[TBL] [Abstract][Full Text] [Related]
29. Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases.
Kimura T; Miyatake T; Ueda Y; Ohta Y; Enomoto T; Kimura T; Kamiura S
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):200-4. PubMed ID: 22770633
[TBL] [Abstract][Full Text] [Related]
30. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
Thuss-Patience PC; Shah MA; Ohtsu A; Van Cutsem E; Ajani JA; Castro H; Mansoor W; Chung HC; Bodoky G; Shitara K; Phillips GDL; van der Horst T; Harle-Yge ML; Althaus BL; Kang YK
Lancet Oncol; 2017 May; 18(5):640-653. PubMed ID: 28343975
[TBL] [Abstract][Full Text] [Related]
31. Angiosarcoma of the scalp and face: the Mayo Clinic experience.
Patel SH; Hayden RE; Hinni ML; Wong WW; Foote RL; Milani S; Wu Q; Ko SJ; Halyard MY
JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):335-40. PubMed ID: 25634014
[TBL] [Abstract][Full Text] [Related]
32. Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanes.
Kucukoztas N; Oguz A; Rahatli S; Altundag O; Altundag K
J BUON; 2016; 21(5):1076-1081. PubMed ID: 27837607
[TBL] [Abstract][Full Text] [Related]
33. Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. A retrospective analysis.
Semrau S; Gerber B; Reimer T; Klautke G; Fietkau R
Strahlenther Onkol; 2006 Oct; 182(10):596-603. PubMed ID: 17013573
[TBL] [Abstract][Full Text] [Related]
34. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
Schlemmer M; Reichardt P; Verweij J; Hartmann JT; Judson I; Thyss A; Hogendoorn PC; Marreaud S; Van Glabbeke M; Blay JY
Eur J Cancer; 2008 Nov; 44(16):2433-6. PubMed ID: 18771914
[TBL] [Abstract][Full Text] [Related]
35. Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes.
Oh WK; Manola J; Babcic V; Harnam N; Kantoff PW
Urology; 2006 Jun; 67(6):1235-40. PubMed ID: 16765185
[TBL] [Abstract][Full Text] [Related]
36. Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Takashima T; Mukai H; Hara F; Matsubara N; Saito T; Takano T; Park Y; Toyama T; Hozumi Y; Tsurutani J; Imoto S; Watanabe T; Sagara Y; Nishimura R; Shimozuma K; Ohashi Y;
Lancet Oncol; 2016 Jan; 17(1):90-8. PubMed ID: 26617202
[TBL] [Abstract][Full Text] [Related]
37. Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp.
Guadagnolo BA; Zagars GK; Araujo D; Ravi V; Shellenberger TD; Sturgis EM
Head Neck; 2011 May; 33(5):661-7. PubMed ID: 20960566
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
Okazawa-Sakai M; Yokoyama T; Fujimoto E; Okame S; Shiroyama Y; Yokoyama T; Takehara K
Int J Clin Oncol; 2018 Aug; 23(4):715-725. PubMed ID: 29446043
[TBL] [Abstract][Full Text] [Related]
39. Treatment of cardiac angiosarcoma with radiation and docetaxel: a case report with partial response and prolonged stable disease.
Suderman D; Cooke A; Wong R; Klein J
J Thorac Oncol; 2011 Apr; 6(4):834-5. PubMed ID: 21623260
[No Abstract] [Full Text] [Related]
40. Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.
Nishio S; Katsumata N; Matsumoto K; Tanabe H; Yonemori K; Kouno T; Shimizu C; Ando M; Kamura T; Kasamatsu T; Fujiwara Y
J Cancer Res Clin Oncol; 2009 Apr; 135(4):551-7. PubMed ID: 18830625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
